// App-Quantinova.ai

84 P-1-39 : Evaluation of Ability of Urinary Podocalyxin, Nephrin and Liver type Fatty Acid Binding Protein for Early Diagnosis in Renal Injury in Adolescents with Type 1 Diabetes

Researchers

Presenter

  • Seniha Kiremitci Yilmaz

Principal Investigators

  • Fatma Taneli

  • Arzu Oran

  • Gulgun Yilmaz Ovali

  • Betul Ersoy

Medical Centers

  • Division of Pediatric Endocrinology and Metabolism, School of Medicine, Celal Bayar University, Manisa, Turkey

  • Department of Clinical Biochemistry, School of Medicine, Celal Bayar University, Manisa, Turkey

  • Department of Clinical Biochemistry, School of Medicine, Celal Bayar University, Manisa, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 1 diabetes mellitus

  • Acute renal failure

  • Diabetes

Biomarkers

  • Nucleoside diphosphate kinase A

  • Podocalyxin

  • Hemoglobin A1c

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final